Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera”), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Our lead product is ILUVIEN, now approved for marketing in the U.S. and 15 European countries for the treatment of diabetic macular edema.
Location: United States, Georgia, Alpharetta
Employees: 201-500
Phone: +1 678-990-5740
Founded date: 2003
Investors 4
Date | Name | Website |
- | Domain Ass... | domainvc.c... |
07.08.2021 | New Enterp... | nea.com |
- | Hercules C... | htgc.com |
- | Sofinnova ... | sofinnova.... |
Mentions in press and media 11
Date | Title | Description | Source |
07.03.2024 | Alimera Sciences Reports Fourth Quarter and Full Year 2023 R... | - | globenewsw... |
02.06.2022 | Alimera Sciences to Present at the LD Micro Invitational XII... | ATLANTA, June 02, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a glob... | globenewsw... |
14.04.2021 | ALIMERA SCIENCES, INC. Alimera Sciences : Receives $20 Mill... | Alimera grants exclusive license to Ocumension for a $10 million upfront payment and up to $89 milli... | marketscre... |
14.04.2021 | Alimera Sciences, Inc. announced that it has received $10 mi... | Alimera Sciences, Inc. (NasdaqGM:ALIM) announced that it has entered into a share purchase agreement... | marketscre... |
18.02.2014 | Alimera raises $37.5M in private placement | Alimera Sciences (NSDQ:ALIM) raised $37.5 million in a recent funding round, planning on using the f... | massdevice... |
03.10.2012 | Biotech company developing therapies for macular edema raise... | Solution/Product: The company makes the Iluvien drug delivery system that is implanted at the back o... | medcitynew... |
23.04.2010 | Morning Read: Americans more confused than angry over health... | Why people hate insurance companies: Reuters has a stunning story about Wellpoint, the nation’s larg... | medcitynew... |
18.03.2008 | Life-science briefing: Tuesday, March 18, 2008 | TODAY’S HEADLINES: Luminous Medical raises $24M for automated glucose monitoring (release) Alimera S... | venturebea... |
17.01.2008 | Life sciences briefing: Thursday, Jan. 17, 2007 | TODAY’S HEADLINES: TransEnterix gets $21M for minimally invasive GI surgery (release) Stem-cell deve... | venturebea... |
- | Morning Read: Americans more confused than angry over health... | Highlights of the important and the interesting from the world of healthcare: Americans more confuse... | medcitynew... |
Show more